MarketCap
Facebook
X
TelegramQuidel Corporation Total Assets 2011-2026 | QDEL
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Quidel Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.87 B | 911 M | 806 M | 935 M | 388 M | 407 M | 452 M | 271 M | 242 M | 279 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.87 B | 242 M | 656 M |
Total Assets of other stocks in the Diagnostics research industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
85.8 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
77.2 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
586 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
467 M | $ 92.0 | 3.42 % | $ 4.3 B | USA |
|
Akumin
AKU
|
1.77 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
24.7 M | $ 5.76 | 11.41 % | $ 7.66 M | USA |
 |
Castle Biosciences
CSTL
|
579 M | $ 21.68 | 6.33 % | $ 628 M | USA |
 |
Aspira Women's Health
AWH
|
5.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
28.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
1.21 B | $ 19.86 | 9.48 % | $ 611 M | USA |
 |
Guardant Health
GH
|
2.01 B | $ 133.0 | 4.7 % | $ 16.7 B | USA |
 |
Biocept
BIOC
|
30.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
235 M | - | - | $ 562 M |  Britain |
 |
ICON Public Limited Company
ICLR
|
16.3 B | $ 152.75 | 6.15 % | $ 12 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
413 M | $ 23.0 | 3.09 % | $ 1.23 B | USA |
 |
Chembio Diagnostics
CEMI
|
62.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Illumina
ILMN
|
6.64 B | $ 167.87 | -1.79 % | $ 26 B | USA |
 |
Check-Cap Ltd.
CHEK
|
7.49 M | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
33.8 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
17.8 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
8.53 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
325 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
6.19 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
975 M | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
3.71 B | $ 1 178.83 | 0.75 % | $ 24.3 B |  Schweiz |
 |
DermTech
DMTK
|
122 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
2.23 B | $ 102.5 | 2.24 % | $ 6.92 B | USA |
 |
NeoGenomics
NEO
|
1.36 B | $ 11.47 | 13.12 % | $ 1.47 B | USA |
 |
Charles River Laboratories International
CRL
|
7.14 B | $ 186.15 | 3.39 % | $ 9.23 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.18 B | - | - | $ 10.7 B | USA |
 |
Natera
NTRA
|
2.4 B | $ 225.67 | 6.52 % | $ 30.9 B | USA |
 |
Medpace Holdings
MEDP
|
1.98 B | $ 457.47 | 1.48 % | $ 13.2 B | USA |
 |
Exact Sciences Corporation
EXAS
|
5.86 B | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
135 M | $ 19.55 | 2.68 % | $ 438 M | USA |
 |
Myriad Genetics
MYGN
|
707 M | $ 4.76 | 8.07 % | $ 441 M | USA |
 |
Personalis
PSNL
|
334 M | $ 12.38 | 14.84 % | $ 1.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
26.9 B | $ 26.0 | 2.52 % | $ 24.7 B |  Niderland |
 |
Senseonics Holdings
SENS
|
126 M | $ 7.03 | 4.61 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.28 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
564 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
5.94 M | $ 2.15 | 1.9 % | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.4 B | $ 260.96 | 0.8 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
642 M | $ 74.75 | 3.35 % | $ 4.47 B | USA |
 |
Thermo Fisher Scientific
TMO
|
110 B | $ 480.69 | 1.4 % | $ 181 B | USA |
 |
Trinity Biotech plc
TRIB
|
103 M | $ 0.68 | -2.84 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
7.22 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
3.44 B | $ 9.13 | 3.58 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
16.2 B | $ 196.31 | 1.29 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
1.95 B | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
5.08 B | $ 377.4 | -0.61 % | $ 22.5 B | USA |